Detalles
This document provides additional guidance in the pharmaceutical and biotechnology sector. This covers: The assessment of nature-related issues using the TNFD's LEAP approach and the disclosure of sector-specific metrics in line with the approach recommended by the TNFD.
Recursos relacionados
Sustainable and Responsible Investment in Spain
Spainsif has published a report on market studies and Sustainable and Responsible Investment (SRI) in Spain. The main innovation of…
New CPIC Conservation Investment Blueprints: A look a success cases of channeling private finance into agriculture and forestry projects
The business case for economic agents to address conservation and its reciprocal relationship with biodiversity is gaining more and more…
2023
Conceptos básicos sobre biodiversidad para preparar a tu empresa para ser positiva para la naturaleza
La plataforma de la UE Business @ Biodiversity organizó un webinario a principios de abril dirigido a organizaciones interesadas en…